Frequency: Weekly (Goes into printing every Tuesday; On stands …
Launched on 21 December 2000, Chronicle Pharmabiz is the No. 1 Pharma news weekly in the South Asian markets; with a target readership that includes 100% coverage of top and middle …
Akums combines two potent diabetes medicines for enhanced …
2 天之前 · Akums combines two potent diabetes medicines for enhanced treatment efficacy: Our Bureau, Bengaluru Tuesday, February 4, 2025, 15:30 Hrs [IST] Akums Drugs and …
Vertex Pharmaceuticals’ suzetrigine gets US FDA approval for …
5 天之前 · Vertex Pharmaceuticals Incorporated, an American biopharmaceutical company based in Boston, announced that the US Food and Drug Administration (FDA) has approved its …
News - Pharmabiz.com
Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, …
Editorial - pharmabiz.com
2024年11月6日 · Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic …
India's most comprehensive portal on pharmaceutical News, …
Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, …
Biocon Biologics completes one-year as an integrated global …
2025年1月8日 · Biocon Biologics in its first anniversary as a fully integrated, global biosimilars company dedicated to expanding access to high-quality affordable biologic medicines for …
Sandoz completes acquisition of antifungal agent Mycamine from …
2023年8月28日 · Sandoz completes acquisition of antifungal agent Mycamine from Astellas: Basel Monday, August 28, 2023, 15:00 Hrs [IST] Sandoz, a global leader in generic and …
US FDA grants Emergency Use Authorization to Novavax 2024 …
2024年9月2日 · US FDA grants Emergency Use Authorization to Novavax 2024-2025 Formula Covid-19 vaccine to prevent Covid-19 in individuals aged 12 and older
Pfizer’s Hympavzi receives US FDA approval to treat adults and ...
2024年10月14日 · Pfizer’s Hympavzi receives US FDA approval to treat adults and adolescents with haemophilia A or B without inhibitors: New York Monday, October 14, 2024, 18:00 Hrs [IST]